Studies how the public reacts to facial skin and hair conditions
Compares public reactions to facial psoriasis, eczema, vitiligo and alopecia areata in adults.
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Roma, ItalySee the site
- Trial code
- Registry title
- Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 1 Feb 2025
- Planned end
- 1 Mar 2026
- Type of study
- Observational
- Record updated
- 26 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults from the general population who do not have these skin diseases and have no personal knowledge of them. It studies how people react to faces affected by these diseases.
- Age
- Over 18 years
- Sex
- Both sexes can join
Main reasons for not taking part
- Diagnosed with psoriasis, atopic dermatitis, vitiligo or alopecia areata
- A close relative (first-degree) with one of these diseases
- Direct knowledge of these diseases for professional or personal reasons
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- -Patients aged>18 years, both sexes
- Signature of written informed consent
Who cannot take part
- Those who for professional or personal reasons have direct knowledge of the diseases in question
- Patients diagnosed with psoriasis, atopic dermatitis, vitiligo or alopecia areata
- Patients with first-degree relatives with psoriasis, atopic dermatitis, vitiligo or alopecia areata
Where in Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC DermatologiaRoma, ItalyContact: Giacomo Caldarola, MDTaking people
About the trial
What the trial wants to find out
Primary objective:
Read full original descriptionShow less
The primary objective is to evaluate in the general population the difference between emotional reactions associated with facial involvement by four major dermatologic diseases: psoriasis, atopic dermatitis, vitiligo, and alopecia areata.
* Compare the social distance and stereotyping by the general population toward individuals with facial involvement by: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Evaluate demographic factors that describe a greater tendency toward stigmatization.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
- Plain-language title
- Studies how the public reacts to facial skin and hair conditionsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 26 August 2025